Case File
efta-efta01119227DOJ Data Set 9Othersep.23.2013 02:01 PM
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta01119227
Pages
6
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
sep.23.2013 02:01 PM
ATM: DAKKEN
FRoM c SUSAN
PAGES
e including
this page
PAGE. 1/ 6
EFTA01119227
Sep.23.2013 02:01 PM
PAGE.
2/ 6
J.P.Morgan
John R. Duffy
Ch44 Executive Officer
U.S. Privets Bank
September 20, 2013
Mr. Jeffrey Epstein
9 East 71" Street
New York, N.Y. 10021
Dear Jeffrey:
In order to assist with an orderly transition of your business to another provider, we are attaching a
list of your accounts with us. This list provides, by entity and by service, the business you will
need to close and re-establish with your new bank.
We wanted to provide a timeline for an orderly exit. The transition of cash accounts (personal and
business checking and savings accounts), should be the first priority. We would appreciate a
transition of these accounts within the next 30 days.
For trading activity we should limit current activity to cash trades and closing trades for
options/derivatives activity. You currently have options positions that may require your brokerage
accounts to remain open through year-end. However, we would expect that you can have brokerage
accounts established with your new provider within the next 30 days. Custody accounts should be
able to be transitioned within a similar timeframe.
Credit facilities may require additional time. You will find balances outstanding as of September
12th in the attached schedule of accounts for both credit cards and line of credit activity. While
these facilities may require some additional time to transition we would expect that within 60 days
this activity can be transitioned to your new bank.
We will work with you and your family office to make this transition smooth, orderly and
straightforward. Do not hesitate to discuss with us your needs and points of coordination with your
new bank that will ease the transition.
ANrue
JYANonmSocultinl0
ilWommehamOWCNA.
WAsibsb w ONteed Ibrou01.0. Macon SecunDob RC veneer NYSE. MAU W SVC
Oa* roan
MO sonic,* Ea lewd by JPIENVEI OWN BANN NA EV Q OEMs.
EFTA01119228
Wd TO:ZO £TOZ'£Z'dag
Jeffrey Epstein
September 2013
Account Review
Investment product= Not FDIC Insured • No bank guarantee • May lose value
3
Please see important information at the end of this pmentation.
J.P.Morgan
EFTA01119229
Account Summary
Values as of September 32. 2013
Starawd CuttcOy {WM lIPIKSO
Wel CM* Dullness Cleating
$242.30.22
1,181,6il 5.99
T0181
Total
Total
TOtAi
Tonal
eget
Total
J.P Morgan
DARREN K. "'DYKE IRA ROttCrillt
DARKS( K game PU.0
DAMPS K INDTKE PILC Any TM ACCT-
C MUT FUNDS ACCOUNT
(Si =DARREN K. MMUS PU.0 -CLIENT
cane Funds /*IDA
RAPS SLID ACCOUNT
MIRK ASSOCIATES INC
IMNRION AIR MC
NYPEAION AIR INC
NY MUCK All INC
NYSKILION AM LLC
MIMS. PC.
NB! "NC
RGE lit
ilEMISI 'EPSTEIN
JEMMY [MEM
JEFFREY EPSTEIN
TN! 2007 JEFTIWI
EPSTEIN INSURANCE
MST $3 MD I3 / 01/2007 D MOM
NEIMAN ITEM
IMAM EPSTEIN
Mink
' , MeV1 .
WAX POUNDATION
NAT FOUNDATION
MOAT INC.
NEPTUNE Lit
Wsl Chant Wads Checking
NH Clank Dulness Clucking
Clank SUINTIOU Checking
CD 32-14 SK)/(MS
Cesellt /Katy
NM Clank Staines, C heeldnp
Slangard Casts* Wel MCl/
WN Chalk (tmlness [Uniting
JPPICIsalc Inninass Checking
Mrs* Cant Checking Pin
Pisa Mat Savings
Pante antChecking as
WM Musk Due ClUcialog pane
Stilltlard Custody
Copan hdlg
"NORCAN ENISINESS SAVINGS
NUT Classic Dus Checking e/Int
AN Ctasslc Dusk u.> Cheating
Chew Sett Banking
Chase Savings
NH Classic Busbies* Chocking
yie,52S.44
$34,525.44
$141,943.91
$0.00
6,566,145.12
$33473.42
$33,673.47
$106,075.67
$100.000.00
$100,000.00
1699.94
6306.775,61
$25,056,046.89
1.23,056.04.6.09
3104,92746
967,935.81
$172,493.67
31.315,41654
tscrosts
353.930.56
$188.65
$0.00
$0.00
lAzas,31$4.60
$17,206.99
$3,542.60
320,74939
30.00
$369.45
$743
$377.21
1 221.334212
$40,314.44z
Nem. note: This is not an official record of your Wounts. Please see your J.P. Morgan statements for an official record.
£i0Z'£Z'des
C)
O
x
0
EFTA01119230
/C.11<.lien
Account Summary (Cont"d)
Valnes as of September 12, 2013
na, LLC
Todal
New YORK STRATEGY GRDAJ.., LIC
MEW YORK STRATEGY CAMP, LIC
NEW YORK STRATEGY GAGU/ I IC IGLA
TRUST AC COUNT
Total
r ^.1
PLSJs D RIC
SOlMet/I FINSUICIAL. LEC
SOLMIENUI I1NANCIAL. Ler
SOUTHERN ElkANCLAL LLC
»WIE» niwie
SOISMERA flatar." LIC -NON
SOUTNERN MMMCML LIC
SOWITEM. FIKANCIA1 ILL
SOUTHERN FINANCIAL LL.0
SalffNeN FUUMCIM. LLL
SOUTHEIN FIJUJICIAL LLC
SOLEMERN ELNANCIAl. LIC•MCN
SOUTInld TRUST COMPANY. INC
SOlfTHEILN TRUST COMPANY. WC
S011~4 TRUST COMPANY. INC
SOWNERSI TRUST CORPS" WC
SOUTNEIUI1RDST CONSUff. INC
SOLIDEM. TRUST COMPANY. DIC44GM
SOUTHERSI TRUST COSIIAlly, SI C
SOLMIDUI TAUST COMPANY INIC-MCN
sowami TUST COMPANY. nic
SOUTRERNTItltsT COME," MC
THE MMMXI
THE MRZE TRUST
ME NAZI TRUST
ME KRZE TRIEST-SIGN
»MED Lle MUTE
ADVIS«. talt CONINIT
ADVISED UNE NOTE
ADVESED ULE ~IT
fl ir Of Cn
NYLIM ar Gult
lit beeurinstl lan
J. P Morgan
MI Choic isctmss C kutklutt
561.666.54
tillaLS4
Cbsalc Putre= ChacklAf
$87$31.12
).MORGAM ITUSDIESS SAVLEIGS
$n.1•6.10
IOLTA Arsoan
10.00
11141i9S5
~flisut
Buslosou ClectS40
$699.S.
1,9-94
~nt
ty
CMV. lEttSI)
$71.170,560.95
SModanl Custody (wtth SUSI)
524.5414132.97
°edit ~y
SL214,19142
JEM Glasa; talnu. Dudki
1330.)21.0S
L114,640.7S
Cut« Sosy
316.122.63
C recet Nu"
f0.00
C teft SUcllity
$000
Cna ~Ry
SOØ
Dormebuss
30.03
Mulitu
S0.00
.97,407,421.11
)PmORGAN EUSIRESS SAVINGS
SULTS4665.04
Standeed Cum« f Wø »NSI/
$S.SUM3142
Stauded Costoety (With »ICI)
14,713,110-15
Cne holu(
D.151.90431
MI C lenk ~nos CNolUsg
$372.921.98
Wroto
nasSes
Cna Fodity
mantr
LO»
Dethavus
10.00
Cni« For"
$0.00
MI,S44$1239
~ost
Gat
(WRI JyttSI)
t21.1T).T)S.TI
liP14011C4N BUSINESS SAVINGS
S211.364.12
PN Clewsk 6uKMs. (MALW,
salo
M»
T2.to
$22.202,1DiJI3
BMW> UNE NOTE
SOM
ADVIS® 111E Cdli«
W.U.)
ADVISED UNE NOIR
SOU0
ADVIS.» LINE COIBICT
SODO
Mø OrCnNit
$0.00
IS
C« Cne
$0.30
lat ileurlInsti Lan
SI.A/
Please note: This Is not an officlal recold d ycu r accounts. Please ste you r 1.P. Morgan sta tements for an o ffi cial record.
sep.23.2013 02:02 PM
EFTA01119231
Important information
IRS CJrcular 230 Disclosure: IPMongan Chase & Co. and its atilt teS do
not provide tax advice. Accordingly, any discussion of L.S. tax matten
contained herein (including any attachment) is not intended or written
to be used, and cannot be used, in connection with the promotion,
marketing or recommendation by anyone unaffiliated with 19hforgan
Chase & Co. Of any of the matters addressed herein or for the purpose of
avoiding US tax-related penalties.
Fads recipient of this presentation, and each agent thereof, may disclose to any
person without limitation, the U.S. income and franchise tax treatment and tax
structure of die transactions described herein and may disclose all materials of any
kind (including opinions or other tax analyses) provided to each redolent insofar
as the materials relate to a U.S. income or franchise tax strategy provided to said,
recipient by /PMorgan Chase & Co. and Its subsidiaries.
Bank products and services are offered by !,Morgan Giese Bank. N.A. and its
affiliates. Securities products and services are offered by J.P. Morgan Securities
LLC, member NYSE, FINRA and SWC.
This material is not Intended as an offer or solicitation for the purchase or sale of
any financial Instrument J.P. Morgan Securfties LIZ or Its brokerage affiliates may
hold a position or act as market maker In the financial instruments of any issuer
diseased herein or act as an smasher, placement agent advisor or lender to
such issuer. The views and straeletim described herein may not be "liable for all
investors. The discurslon of loans or other extensions of credit in this material is
for illustrative purposes only. No commitment to lend by J.P. Morgan should be
construed or Implied This material is distributed with the understanding that we
are not rendering actountin9, legal or tax advice. Estate planning requires legal
assistance. You should consult with your independent aceirsois concerning
such matters
We believe the information contained In this material to be reliable but do not
warrant Its accuracy or completeness Opinions, estimates. and irwesunent
strategies and views expressed In this document constitute our judgment based
on current market conditions and we subject to change without node. This
material should not be regarded as research or a J.P. Morgan research report.
Opinions expressed herein may differ from the opinions expressed by other areas
of J.P. Morgan, Including research. The investment strategies and views stated
here may differ from those expressed for other purposes or in other contexts by
other J.P. Morgan market strategists.
J.P.Morgan
J.P. Morgan Securities LLC may act as a market maker in markets relevant to
structured product or option products and may engage in hedging or ocher
operations In such markets relevant to it structured works= or options
exposures. Structured products and options are not insured by the Federal Deposit
Insurance Corporation MC, the Federal Reserve Board, or any other
governmental agency.
In discussion of options and other strategies. results and risks are based solely on
hypothetical examples check actual results and risks will vary dee/ruing on
specific drcurnstancm. Investors are urged to consider carefully whether option or
option-related products In general, as well as the product or strategies discuseed
herein are suitable to %Ink needs in actual transaction; the client's counterparty
for OTC derivatives applications is JPMorgan Chase Bank, NA., London branch. For
a copy of the tharacteristia and Risks of Standardized Options" booklet please
contact your it. Morgan Advisor.
Real estate, hedge funds, and other private investments may not be suitable for
all individual investors, may present significant risks, and may be sold or redeemed
at more or less than the original amount invested. Private investments are offered
only by offering memoranda, wbkh more fully describe the passable rides There
are no assurances that the stated investment objectives of any Investment product
will be met. Hedge hinds (or funds of hedge funds): often engage in leveraging
and other speculative investment practices that may increase the risk of
knestrner4 lose on be highly illiquid: are not required to provide periodic pricing
or valuation information to investors; may involve complex tax structures and
delays in distributing Important tax Intl:emotion; are not subject to the same
regulatory requirements as mutual funds; and often charge high fees. Further, any
number of conflict of Wendt may exist in the context of the management andfor
operation of any hedge fund.
IPA/organ Funds are distributed by JPMorgan Distribution Services, Inc., which is
an affiliate of Jahtorgan Chase & Co. Affiliates of WMotgan Chase & Co. receive
fees for providing various services to the funds. CaLl1PMorgan Distribution
Services at 1400-480-4111 or visit wwW.ipmorganfundscom for the prospectus.
Investors shoold carefully consider the investment objectives, risks, charges and
mates of the mutual funds before investing. The prospectus contains this
and other information about the mutUal fund and should be read carefully
before Investing.
As applicable, portions of mutual fund performance information may be provided
by Lipper, a Reuters company, subject to the following: 0 2012 Reuters. All rights
reserved. Any orgying, republicaton or redistribution of tipper content induding
by aiding, framing or similar means, Is mann* prohibited without the prior
written consent of Upper. Upper shall not be liable for any awn or delays in the
content or for any actors taken in reliance thereon.
Past performarsoe is no guanentee of futon results.
Additional Information is available upon request
02013 PlAorgan Chase & Co.
ro
ply
ON
cr‘
EFTA01119232
Technical Artifacts (6)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
IPv4
056.04.6.09Phone
1400-480-4111Phone
524.5414132SWIFT/BIC
JPIENVEISWIFT/BIC
NYPEAIONSWIFT/BIC
STRATEGYRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.